Correlation of positron emission tomography standard uptake value and pathologic specimen size in cancer of the head and neck.

PURPOSE To correlate positron emission tomography (PET) standard uptake value (SUV) with pathologic specimen size in patients with head-and-neck cancers. METHODS AND MATERIALS Eighteen patients with Stage II-IVB head-and-neck cancer with 27 tumors who underwent PET and computed tomography (CT) imaging of the head and neck followed by surgical resection were selected for this study. Various SUV thresholds were examined, including the software default (SUV(def)), narrowing the window by 1 standard deviation (SD) of the maximum (SUV-1SD), and SUV cutoff values of 2.5 or greater (SUV2.5) and 40% or greater maximum (SUV40). Volumetric pathologic data were available for 12 patients. Tumor volumes based on pathologic examination (gold standard), CT, SUV(def), SUV-1SD, SUV2.5, and SUV40 were analyzed. RESULTS PET identified five tumors not seen on CT. The sensitivity of PET for identifying primary tumors was 94% (17 of 18). The Sensitivity of PET for staging the neck was 90% (9 of 10), whereas the specificity was 78% (7 of 9). The SUV2.5 method was most likely to overestimate tumor volume, whereas SUV(def) and SUV-1SD were most likely to underestimate tumor volume. CONCLUSIONS The PET scan provides more accurate staging of primary tumors and nodal metastases for patients with advanced head-and-neck cancer than CT alone. Compared with the gold standard, significant variability exists in volumes obtained by using various SUV thresholds. A combination of clinical, CT, and PET data should continue to be used for optimal treatment planning. The SUV40 method appears to offer the best compromise between accuracy and reducing the risk of underestimating tumor extent.

[1]  Yoshimi Anzai,et al.  FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma. , 2005, International journal of radiation oncology, biology, physics.

[2]  K. Greven,et al.  Positron-emission tomography for head and neck cancer. , 2004, Seminars in radiation oncology.

[3]  Sasa Mutic,et al.  Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. , 2004, International journal of radiation oncology, biology, physics.

[4]  E. Genden,et al.  Adjuvant radiotherapy improves overall survival for patients with lymph node‐positive head and neck squamous cell carcinoma , 2008, Cancer.

[5]  David Schuster,et al.  Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer. , 2005, International journal of radiation oncology, biology, physics.

[6]  K. Geisinger,et al.  A comparative diagnostic study of head and neck nodal metastases using positron emission tomography , 1995, The Laryngoscope.

[7]  Peter A S Johnstone,et al.  FDG-PET in radiotherapy treatment planning: Pandora's box? , 2004, International journal of radiation oncology, biology, physics.

[8]  L. Dawson,et al.  Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing. , 2004, International journal of radiation oncology, biology, physics.

[9]  R. Baum,et al.  Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI. , 2000, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[10]  Anne Bol,et al.  Evaluation of a multimodality image (CT, MRI and PET) coregistration procedure on phantom and head and neck cancer patients: accuracy, reproducibility and consistency. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  A. Riegel,et al.  Variability of gross tumor volume delineation in head-and-neck cancer using CT and PET/CT fusion. , 2005, International journal of radiation oncology, biology, physics.

[12]  V. Grégoire,et al.  Is PET-based treatment planning the new standard in modern radiotherapy? The head and neck paradigm. , 2006, Seminars in radiation oncology.

[13]  G. Hör,et al.  Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer , 1998, European Journal of Nuclear Medicine.

[14]  A. Eisbruch,et al.  Future issues in highly conformal radiotherapy for head and neck cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  T. Yen,et al.  Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  S. Rafla,et al.  The impact of positron emission tomography/computed tomography in edge delineation of gross tumor volume for head and neck cancers. , 2007, International journal of radiation oncology, biology, physics.

[17]  N. Hacker,et al.  Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. , 1990 .

[18]  Brian O'Sullivan,et al.  Intraobserver and interobserver variability in GTV delineation on FDG-PET-CT images of head and neck cancers. , 2007, International journal of radiation oncology, biology, physics.

[19]  Jean-François Daisne,et al.  Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. , 2004, Radiology.

[20]  Jatinder R Palta,et al.  Intensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfalls. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Anil Sethi,et al.  Correlation of PET standard uptake value and CT window-level thresholds for target delineation in CT-based radiation treatment planning. , 2007, International journal of radiation oncology, biology, physics.

[22]  Dwight E Heron,et al.  Hybrid PET-CT simulation for radiation treatment planning in head-and-neck cancers: a brief technical report. , 2004, International journal of radiation oncology, biology, physics.

[23]  M. Schwaiger,et al.  Lymph node detection of head and neck squamous cell carcinomas by positron emission tomography with fluorodeoxyglucose F 18 in a routine clinical setting. , 1999, Archives of otolaryngology--head & neck surgery.

[24]  C. Rübe,et al.  Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[25]  D. Sidransky,et al.  Head and neck cancer. , 2001, The New England journal of medicine.

[26]  B. Cheson,et al.  Positron-emission tomography and assessment of cancer therapy. , 2006, The New England journal of medicine.

[27]  Yoshimi Anzai,et al.  FDG‐PET/CT–guided intensity modulated head and neck radiotherapy: A pilot investigation , 2005, Head & neck.